Age-adjusted HCC incidence rates were calculated from the Centers for Disease Control's United States Cancer Statistics database, which combines incidence data on newly diagnosed cancer cases and ...

Marissa Antonio was just 39 when the 19cm tumour was discovered - and now, Cancer Research UK has revealed liver cancer death ...

A 39 year old nurse has recalled the four key symptoms that potentially saved her life, as she opened up about her critical ...

Background: Hepatoblastoma (HBL) and hepatocellular carcinoma (HCC) are respectively the first and the second most common pediatric malignant liver tumors. The purpose of this study was to ...

Can-Fite BioPharma has secured a US patent for Namodenoson, its lead drug candidate, for use as an anti-obesity treatment.

Like many rare diseases, fibrolamellar hepatocellular carcinoma (FLC) mounts a ferocious attack against an ... a highly ...

The US Food and Drug Administration has granted orphan drug designation (ODD) to Tempest Therapeutics' oral, selective ...

New insights into fibrolamellar hepatocellular carcinoma could lead to new drugs and significantly improved health outcomes.

However, the specific role of EpCAM itself in early-stage hepatocellular carcinoma progression remains unclear, and small molecules targeting EpCAM have not yet been reported. Molecular docking ...